Clinical Trials
3 trialsNCT04458909 2025-10-03
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00393224 2020-06-04
Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families
National Institutes of Health Clinical Center (CC)
Terminated
NCT01257100 2020-06-04
Environmental and Genetic Determinants of NPC
National Institutes of Health Clinical Center (CC)
Terminated